Orphan Drugs: A Growing Opportunity for Health Systems

Orphan Drug Strategies to Help 340B Health Systems Achieve More

By McKesson Health Systems Editorial Team

Date

November 01, 2023

Read time: 8 minutes

By: McKesson Health Systems Editorial Team

Orphan drugs have been making headlines for decades — not only for bringing new treatment options to patients with rare conditions and diseases, but also for notoriously high costs that are rewriting the rules for pricing, discounts, and reimbursement.

In this eBook, we’ve curated key drivers, trends, and statistics to help health systems put today’s orphan drug issues into perspective.

Download the eBook to learn how McKesson can help you achieve more for your business of pharmacy.

Subscribe Now

To learn how McKesson can help health systems achieve more, sign up to have the Prescribed Perspectives newsletter delivered directly to your inbox.

Brittany Ulrich, PharmD, CSP, BCBBS, examines how limited distribution drugs and payer requirements push specialty prescriptions outside the organization, eroding visibility into patient outcomes, and how Biologics by McKesson helps health systems expect more when it comes to maintaining care continuity.

Researcher in a laboratory looks through shelving lined with containers and supplies.

What You Should Know About the CMS Proposed 340B Payment Change

Dr. Andrew Wilson, B.S., Pharm.D., FASHP, reflects on the proposed CY 2027 OPPS rule for several outpatient drugs purchased through the 340B program, and the next phase of specialty drug margin management for the business of pharmacy.

Open laptop beside a stack of tabbed documents in a binder on a desk, with a softly blurred office background.

Top Prescribed Perspectives Reads for August

The top three Prescribed Perspectives articles most read by health systems in August.

Healthcare professional and colleague review information on a tablet in a clinical setting.

Where Does Your Health System Fall on the Specialty and Infusion Growth Journey?

With our assessment, benchmark your progress across the specialty and infusion journey to achieve more for the business of pharmacy.

Pharmacy professional reviewing medication shelves while holding a tablet.

Expert Q&A: Building the Pharmacist of the Future

A conversation with Rafael Saenz, MS, FASHP, on workforce trends impacting the business of pharmacy today.

Pharmacy staff member reviews medication box on shelf, holding device while standing in a stocked pharmacy aisle.

Where High-Performing Specialty Pharmacies Focus Today

Successful specialty pharmacies require continuous monitoring and deliberate refinement, especially across these five areas.

Healthcare worker inserts IV line into a person's hand as the person sits with arm resting in a clinic setting.

3 Ways to Evolve Your Infusion Strategy

In the face of rapid change and growth, health systems must rethink their infusion services. Our Health System Pharmacy Market Outlook Report for 2026 outlines three ways health systems are taking action.

Laboratory microscope beside blood sample tubes and a gloved hand handling test equipment.

Overcoming Challenges in Operationalizing CGT Within Health Systems

McKesson’s Head of Cell, Gene, and Advanced Therapies discusses opportunities and challenges with CGT in the health system.

Orphan Drugs: A Growing Opportunity for Health Systems

Related Stories

Related Tags